STOCK TITAN

Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Psyence Biomedical announced its participation in the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024. The company's management will host one-on-one meetings with investors during the event. This provides an opportunity for investors to engage directly with the company's leadership and gain insights into Psyence Biomed's business strategy and future plans.

Positive
  • Participation in a notable healthcare event increases visibility and investor interest.
  • Direct engagement with investors can boost confidence and transparency.
Negative
  • No new product launches or financial performance updates were announced.
  • Investors looking for concrete data or significant news may be disappointed.

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the A.G.P. Virtual Healthcare Company Showcase, which is being held May 21, 2024.

For more information, or to register: https://allianceg.com/events/.

About Psyence Biomed

Psyence Biomedical Ltd., a corporation organized under the laws of Ontario, Canada, is the world’s first life science biotechnology company traded on The Nasdaq Stock Market LLC (“Nasdaq”) (Nasdaq:PBM) that is focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name “Psyence” combines the words “psychedelics” and “science” to affirm Psyence Biomed’s commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health disorders. Psyence Biomed is initially focused on mental health disorders in the context of Palliative Care.

Learn more at www.psyencebiomed.com and on LinkedIn.

Contact Information
Email: ir@psyencebiomed.com
Media Inquiries: media@psyencebiomed.com
General Information: info@psyencebiomed.com
Phone: +1 416-477-1708

Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com


FAQ

When is Psyence Biomed participating in the A.G.P. Virtual Healthcare Company Showcase?

Psyence Biomed is participating on May 21, 2024.

What is the ticker symbol for Psyence Biomed?

The ticker symbol for Psyence Biomed is PBM.

What will Psyence Biomed do at the A.G.P. Virtual Healthcare Company Showcase?

The company's management will host one-on-one meetings with investors.

Where can I find more information about Psyence Biomed's participation in the event?

More information and registration details can be found at https://allianceg.com/events/.

Psyence Biomedical Ltd. Common Shares

NASDAQ:PBM

PBM Rankings

PBM Latest News

PBM Stock Data

3.37M
54.33M
17.59%
6.5%
1.51%
Biotechnology
Healthcare
Link
United States of America
Toronto